Literature DB >> 18641997

New observations concerning the interpretation of magnetic resonance spectroscopy of meningioma.

Qiang Yue1, Tomonori Isobe, Yasushi Shibata, Izumi Anno, Hiraku Kawamura, Youhei Yamamoto, Shingo Takano, Akira Matsumura.   

Abstract

This study was aimed to clarify some ambiguities in the interpretation of proton magnetic resonance spectroscopy (1H-MRS) of meningiomas. The cases of 31 meningioma patients (27 benign and 4 nonbenign meningiomas) that underwent single-voxel 1H-MRS (PRESS sequence, TR/TE = 2,000 ms/68, 136, 272 ms) were retrospectively analyzed. To verify the findings of in-vivo study, phantoms were measured, and pathological sections of 11 patients were reviewed. All meningiomas demonstrated increased choline and decreased creatine, except for a lipomatous meningioma that only displayed a prominent lipid (Lip) peak. Alanine (Ala) and lactate (Lac) coexisted in eight cases, indicating an alternative pathway of energy metabolism in meningiomas. They partially overlapped with each other and demonstrated a triplet-like spectral pattern, which was consistent with phantom study. Glutamine/glutamate (Glx) was helpful for the recognition of meningioma when Ala was absent. N-acetyl compounds(NACs) were observed in nine cases whose voxels were completely limited within the tumors, indicating that meningiomas might have endogenous NACs. Lac was indicative of an aggressive meningioma, although not always a nonbenign one. Lip not only represented micronecrosis in nonbenign meningiomas, but also reflected microcystic changes or fatty degeneration in benign meningiomas. 1H-MRS reflects some distinctive biochemical and pathological changes of meningiomas that might be misinterpreted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641997     DOI: 10.1007/s00330-008-1079-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  38 in total

1.  Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.

Authors:  Y Kinoshita; A Yokota
Journal:  NMR Biomed       Date:  1997-01       Impact factor: 4.044

2.  Approaches to editing, assignment and interpretation of proton spectra.

Authors:  D G Gadian; T E Bates; S R Williams; J D Bell; S J Austin; A Connelly
Journal:  NMR Biomed       Date:  1991-04       Impact factor: 4.044

3.  Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy.

Authors:  L L Cheng; M J Ma; L Becerra; T Ptak; I Tracey; A Lackner; R G González
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components.

Authors:  F G Lehnhardt; G Röhn; R I Ernestus; M Grüne; M Hoehn
Journal:  NMR Biomed       Date:  2001-08       Impact factor: 4.044

5.  Magnetic resonance spectroscopy of brain hemangiopericytomas: high myoinositol concentrations and discrimination from meningiomas.

Authors:  I Barba; A Moreno; I Martinez-Pérez; A R Tate; M E Cabañas; M Baquero; A Capdevila; C Arús
Journal:  J Neurosurg       Date:  2001-01       Impact factor: 5.115

6.  Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.

Authors:  Saman Hazany; John R Hesselink; John F Healy; Steven G Imbesi
Journal:  Neuroradiology       Date:  2006-11-04       Impact factor: 2.804

7.  Fluorescent in situ hybridization and ex vivo 1H magnetic resonance spectroscopic examinations of meningioma tumor tissue: is it possible to identify a clinically-aggressive subset of benign meningiomas?

Authors:  Wolfgang K Pfisterer; William P Hendricks; Adrienne C Scheck; Ronald A Nieman; Thomas H Birkner; Wolfgang W Krampla; Mark C Preul
Journal:  Neurosurgery       Date:  2007-11       Impact factor: 4.654

8.  Human brain tumors: assessment with in vivo proton MR spectroscopy.

Authors:  D Ott; J Hennig; T Ernst
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

9.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.

Authors:  H Bruhn; J Frahm; M L Gyngell; K D Merboldt; W Hänicke; R Sauter; C Hamburger
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

10.  Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS.

Authors:  K S Opstad; S W Provencher; B A Bell; J R Griffiths; F A Howe
Journal:  Magn Reson Med       Date:  2003-04       Impact factor: 4.668

View more
  16 in total

Review 1.  A review of malignant meningiomas: diagnosis, characteristics, and treatment.

Authors:  Simon Hanft; Peter Canoll; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2010-08-21       Impact factor: 4.130

2.  The relevance between symptoms and magnetic resonance imaging analysis of the hippocampus of depressed patients given electro-acupuncture combined with Fluoxetine intervention - A randomized, controlled trial.

Authors:  Dong-Mei Duan; Ya Tu; Shuang Jiao; Wen Qin
Journal:  Chin J Integr Med       Date:  2011-02-27       Impact factor: 1.978

Review 3.  Molecular imaging of brain tumors with radiolabeled choline PET.

Authors:  Ferdinando Franco Calabria; Manlio Barbarisi; Vincenzo Gangemi; Giovanni Grillea; Giuseppe Lucio Cascini
Journal:  Neurosurg Rev       Date:  2016-05-26       Impact factor: 3.042

Review 4.  Uncommon Cranial Meningioma: Key Imaging Features on Conventional and Advanced Imaging.

Authors:  Nader Zakhari; Carlos Torres; Mauricio Castillo; Thanh B Nguyen
Journal:  Clin Neuroradiol       Date:  2017-05-02       Impact factor: 3.649

5.  Prediction of high-grade meningioma by preoperative MRI assessment.

Authors:  Yosuke Kawahara; Mitsutoshi Nakada; Yutaka Hayashi; Yutaka Kai; Yasuhiko Hayashi; Naoyuki Uchiyama; Hiroyuki Nakamura; Jun-Ichi Kuratsu; Jun-Ichiro Hamada
Journal:  J Neurooncol       Date:  2012-02-12       Impact factor: 4.130

6.  Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.

Authors:  Alan J Wright; Greg A Fellows; John R Griffiths; M Wilson; B Anthony Bell; Franklyn A Howe
Journal:  Mol Cancer       Date:  2010-03-23       Impact factor: 27.401

7.  Distinct peak at 3.8 ppm observed by 3T MR spectroscopy in meningiomas, while nearly absent in high-grade gliomas and cerebral metastases.

Authors:  Evanthia Kousi; Ioannis Tsougos; Konstantinos Fountas; Kiriaki Theodorou; Evaggelia Tsolaki; Ioannis Fezoulidis; Eftichia Kapsalaki
Journal:  Mol Med Rep       Date:  2012-01-30       Impact factor: 2.952

8.  Magnetic resonance imaging of meningiomas: a pictorial review.

Authors:  J Watts; G Box; A Galvin; P Brotchie; N Trost; T Sutherland
Journal:  Insights Imaging       Date:  2014-01-08

Review 9.  In vivo magnetic resonance spectroscopy: basic methodology and clinical applications.

Authors:  Marinette van der Graaf
Journal:  Eur Biophys J       Date:  2009-08-13       Impact factor: 1.733

10.  Utility of 3T single-voxel proton MR spectroscopy for differentiating intracranial meningiomas from intracranial enhanced mass lesions.

Authors:  Eiji Matsusue; Chie Inoue; Sadaharu Tabuchi; Hiroki Yoshioka; Yuichiro Nagao; Kensuke Matsumoto; Kazuhiko Nakamura; Shinya Fujii
Journal:  Acta Radiol Open       Date:  2021-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.